Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Incyte Corporation
Regeneron Pharmaceuticals
Novartis
Shattuck Labs, Inc.
UNC Lineberger Comprehensive Cancer Center